The EMA has defined a road map for reporting medicinal product data – substance, product, organization, and referential (SPOR).
Goals and Objectives
Assisting pharmacovigilance efforts, reducing counterfeiting, and allowing for tracking of product
MDM, cloud, IoT (later for track and trace)
Use Case Summary
The standardization of MDM for product SPOR data and central data repository will foster drug safety and product identification.